232 related articles for article (PubMed ID: 10779344)
1. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
2. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
3. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
Gontarek RR; Derse D
Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
[TBL] [Abstract][Full Text] [Related]
4. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
7. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
8. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
9. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
10. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
11. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
12. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.
Harris ME; Gontarek RR; Derse D; Hope TJ
Mol Cell Biol; 1998 Jul; 18(7):3889-99. PubMed ID: 9632773
[TBL] [Abstract][Full Text] [Related]
13. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
14. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
[TBL] [Abstract][Full Text] [Related]
15. Biological characterization of Rev variation in equine infectious anemia virus.
Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
[TBL] [Abstract][Full Text] [Related]
16. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.
Yi R; Bogerd HP; Cullen BR
J Virol; 2002 Mar; 76(5):2036-42. PubMed ID: 11836381
[TBL] [Abstract][Full Text] [Related]
18. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
[TBL] [Abstract][Full Text] [Related]
19. Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.
Umunnakwe CN; Loyd H; Cornick K; Chavez JR; Dobbs D; Carpenter S
Retrovirology; 2014 Dec; 11():115. PubMed ID: 25533001
[TBL] [Abstract][Full Text] [Related]
20. Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer.
Asang C; Hauber I; Schaal H
Nucleic Acids Res; 2008 Mar; 36(5):1450-63. PubMed ID: 18203748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]